Douglas Mulligan*
This article provides an in-depth exploration of drug development, a critical process in healthcare that aims to discover and create novel medications to address various diseases and improve patient outcomes. The article outlines the key stages involved in drug development, including target identification, preclinical testing, clinical trials, and regulatory approval. Additionally, it discusses the challenges and advancements in this field, such as personalized medicine, artificial intelligence, and emerging technologies. The article concludes by highlighting the significance of continuous innovation and collaboration in drug development to meet the evolving needs of patients worldwide.
この記事をシェアする
English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 